IdentificationGeneric Name(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidiniumDrugBank Accession NumberDB03881BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium (DB03881)× CloseWeightAverage: 297.353 Monoisotopic: 297.10213612 Chemical FormulaC12H17N4O3SSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUPurine nucleotide phosphorylase, putativeNot AvailablePlasmodium falciparum (isolate 3D7)UPurine nucleoside phosphorylaseNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as pyrrolopyrimidines. These are compounds containing a pyrrolopyrimidine moiety, which consists of a pyrrole ring fused to a pyrimidine. Pyrrole is 5-membered ring consisting of four carbon atoms and one nitrogen atom. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassPyrrolopyrimidinesSub ClassNot AvailableDirect ParentPyrrolopyrimidinesAlternative ParentsPyrimidones / Aralkylamines / Substituted pyrroles / Vinylogous amides / Quaternary ammonium salts / Pyrrolidines / Heteroaromatic compounds / 1,2-aminoalcohols / Secondary alcohols / 1,2-diols / Sulfenyl compounds / Azacyclic compounds / Dialkylamines / Dialkylthioethers / Organic oxides / Hydrocarbon derivatives / Organic cations


 show 7 moreSubstituents1,2-aminoalcohol / 1,2-diol / Alcohol / Amine / Aralkylamine / Aromatic heteropolycyclic compound / Azacycle / Dialkylthioether / Heteroaromatic compound / Hydrocarbon derivative / Organic cation / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organosulfur compound / Pyrimidine / Pyrimidone / Pyrrole / Pyrrolidine / Pyrrolopyrimidine / Quaternary ammonium salt / Secondary alcohol / Secondary aliphatic amine / Secondary amine / Substituted pyrrole / Sulfenyl compound / Thioether / Vinylogous amide


 show 20 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal Descriptorsdihydroxypyrrolidine, pyrrolopyrimidine (CHEBI:44290) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyCEGIKIXYDFDYDN-RXDXJJGDSA-OInChIInChI=1S/C12H16N4O3S/c1-20-3-6-10(17)11(18)8(16-6)5-2-13-9-7(5)14-4-15-12(9)19/h2,4,6,8,10-11,13,16-18H,3H2,1H3,(H,14,15,19)/p+1/t6-,8+,10-,11+/m1/s1IUPAC Name(2S,3R,4S,5S)-3,4-dihydroxy-2-[(methylsulfanyl)methyl]-5-{4-oxo-1H,4H,5H-pyrrolo[3,2-d]pyrimidin-7-yl}pyrrolidin-1-iumSMILES[H]N1C=C([C@H]2[C@H](O)[C@H](O)[C@@H](CSC)[N+]2([H])[H])C2=C1C(=O)N=CN2[H]ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound131704261PubChem Substance46506174ChemSpider4883415PDBe LigandMTIPDB Entries1q1gClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourcelogP-0.72ChemaxonpKa (Strongest Acidic)12.5ChemaxonpKa (Strongest Basic)8.45ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count5ChemaxonPolar Surface Area114.32 Å2ChemaxonRotatable Bond Count3ChemaxonRefractivity88.19 m3·mol-1ChemaxonPolarizability29.18 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9838Blood Brain Barrier-0.835Caco-2 permeable-0.7163P-glycoprotein substrateSubstrate0.6708P-glycoprotein inhibitor INon-inhibitor0.9827P-glycoprotein inhibitor IINon-inhibitor0.979Renal organic cation transporterNon-inhibitor0.9203CYP450 2C9 substrateNon-substrate0.8061CYP450 2D6 substrateNon-substrate0.7812CYP450 3A4 substrateSubstrate0.5428CYP450 1A2 substrateNon-inhibitor0.7826CYP450 2C9 inhibitorNon-inhibitor0.8315CYP450 2D6 inhibitorNon-inhibitor0.8693CYP450 2C19 inhibitorNon-inhibitor0.81CYP450 3A4 inhibitorNon-inhibitor0.9584CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8782Ames testNon AMES toxic0.7057CarcinogenicityNon-carcinogens0.9506BiodegradationNot ready biodegradable0.9794Rat acute toxicity2.4136 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9915hERG inhibition (predictor II)Non-inhibitor0.7918  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Purine nucleotide phosphorylase, putativeKindProteinOrganismPlasmodium falciparum (isolate 3D7)Pharmacological actionUnknownGeneral FunctionUridine phosphorylase activitySpecific FunctionNot AvailableGene NameNot AvailableUniprot IDQ8I3X4Uniprot NamePurine nucleotide phosphorylase, putativeMolecular Weight26857.88 Da


 Details2. Purine nucleoside phosphorylaseKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionPurine-nucleoside phosphorylase activitySpecific FunctionThe purine nucleoside phosphorylases catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine ...Gene NamePNPUniprot IDP00491Uniprot NamePurine nucleoside phosphorylaseMolecular Weight32117.69 DaReferencesShi W, Ting LM, Kicska GA, Lewandowicz A, Tyler PC, Evans GB, Furneaux RH, Kim K, Almo SC, Schramm VL: Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem. 2004 Apr 30;279(18):18103-6. Epub 2004 Feb 23. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 